Quality by design-based method development for the determination of related substances of ezetimibe by high performance liquid chromatography

Author:

Ferencz Elek12,Sipos Emese3,Kelemen Éva-Katalin2,Obreja Mona4,Urkon Melinda5,Tóth Gergő6,Szabó Zoltán-István37

Affiliation:

1. 1 George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures , Department of Physical Chemistry , Targu Mures

2. 3 Gedeon Richter Romania, Product Development Department , Targu Mures

3. 2 George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures , Department of Pharmaceutical Industry and Management , Targu Mures

4. 4 Gedeon Richter Romania, Analytical Development Department , Targu Mures

5. 5 George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures , Department of Pharmacology and Clinical Pharmacy , Targu Mures

6. 6 Semmelweis University, Faculty of Pharmacy , Department of Pharmaceutical Chemistry , Budapest

7. 7 Sz-imfidum Ltd ., Lunga

Abstract

Abstract The pharmaceutical industry is one of the fastest developing industries, and therefore, the chromatographic methods used to ensure the quality of products are constantly evolving, based on current regulatory requirements. Relevant guidelines state that a good understanding of the effects of all parameters on method performance should be predicted and controlled to ensure that test methods are safe and reliable. This quality by design-based approach is increasingly applied in chromatography. One of the pillars of this method development is the design space that results from pre-designed and systematically realized experiments, which contributes to a better understanding of the separation processes and provides flexibility and robustness to the final method. Modeling softwarewares can be used to experimental design and data evaluation, providing possibilities that empirical development does not allow, such as predicting optimal operating conditions or in silico robustness testing, to understand the separation process. This paper describes the steps of chromatographic method development according to the ICH Q14 guideline, keeping in mind the quality by design principles and taking advantage of the possibilities offered by the DryLab chromatographic modeling software. As an example, the development of an analytical method for the determination of the related substances of ezetimibe is presented, including the design of experiments, method optimization, robustness testing, validation, method specification and lifecycle management, and finally testing of the method applicability. We have demonstrated that experimental design-based retention modeling is an effective way of method development, and the in silico robustness testing is a reliable approach to identifying critical method parameters and setting up control strategies. In chromatographic method development, instead of using a rigid system based on strict and fixed rules, the understanding of separation processes offers higher flexibility. This paper aims to present and promote this new approach to those involved in chromatographic method development.

Publisher

Walter de Gruyter GmbH

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3